Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Avène Cleanance Comedomed+
- Development stage
- Unknown
- Lead developer
- Laboratoires Dermatologiques Avène
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Topical
01
Overview
Avène Cleanance Comedomed+ is a topical dermo-cosmetic skincare treatment developed by Laboratoires Dermatologiques Avène (a division of Pierre Fabre) for oily, acne-prone, and blemish-prone skin. It is formulated as a lightweight gel-cream containing 25% Comedoclastin™ (a patented plant extract derived from milk thistle, *Silybum marianum*) and 4% Niacinamide, enriched with Avène Thermal Spring Water. The product targets the formation of microcomedones and micro-inflammation to prevent and reduce blackheads, whiteheads, pimples, and post-acne marks. It is suitable for teenagers and adults, including pregnant women, and has demonstrated anti-relapse efficacy for up to one year.
- Brand names
- Avène Cleanance Comedomed+Avène Cleanance Comedomed+ Anti-Blemishes ConcentrateAvène Cleanance Comedomed+ Anti-Imperfections Intensive Anti-Blemish CareAvène Cleanance Comedomed+ Clarifying CreamAvène Cleanance Comedomed+ Intensive Anti-Blemish CareAvène Cleanance Comedomed+ Soin intensif Anti-imperfections
- Other names
- Cleanance Comedomed+
Beyond the preview
Go deeper on Avène Cleanance Comedomed+.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Avène Cleanance Comedomed+.